Neurocrine Biosciences | Marktkapitalisierung



Market Capitalization Veränderung Datum
AbbVie USD 370.64B 56.62B 2025-03
Agios Pharmaceuticals USD 1.75B 121M 2025-05
ALKERMES USD 4.85B 201M 2025-05
Alnylam Pharmaceuticals USD 33.94B 1.18B 2025-05
Amgen USD 152.46B 12.49B 2025-05
Biogen USD 17.77B 4.51B 2025-05
BioMarin Pharmaceutical USD 12.1B 443M 2025-05
Cytokinetics USD 5.55B 661M 2024-12
Dynavax Technologies USD 1.68B 219M 2024-12
Gilead Sciences USD 139.68B 24.59B 2025-03
Halozyme Therapeutics USD 6.08B 1.17B 2024-12
Incyte USD 11.72B 1.59B 2025-03
Ionis Pharmaceuticals USD 4.8B 722M 2025-03
Neurocrine Biosciences USD 13.82B 2.18B 2024-12
Pfizer USD 143.72B 6.63B 2025-03
Prothena USD 745M 155M 2024-12
Sarepta Therapeutics USD 11.78B 128M 2024-12
Teva Pharmaceutical Industries ILS 91.91B 16.81B 2024-12
Ultragenyx Pharmaceutical USD 3.88B 1.24B 2024-12
Vertex Pharmaceuticals USD 103.45B 16.4B 2024-12



Neurocrine Biosciences Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.